drugset / Trial / NCT01612377

Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01612377

Phase 2 Terminated 18 enrolled Zalicus
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare an experimental drug called Z102 (combination of prednisolone and dipyridamole, against prednisone 5mg and prednisone 7.5mg in patients with moderate to severe Rheumatoid Arthritis for a period of 52 weeks.

Timeline

Start
2012-03
Primary completion
2013-07
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dipyridamole Other / unclassified Oral
Subject Prednisolone Other / unclassified Oral
Comparator Prednisone Other / unclassified 5 mg Oral
Comparator Prednisone Other / unclassified 7.5 mg Oral

Indications